Yes, all three medications—prednisone, albuterol, and Augmentin—are safe to take while breastfeeding.
You can continue breastfeeding while taking this combination of medications without interruption. The evidence strongly supports the safety of each of these drugs during lactation, with minimal infant exposure and no significant adverse effects reported.
Prednisone During Lactation
Prednisone is compatible with breastfeeding at typical therapeutic doses. The 2025 Global Consensus Statement on IBD management provides the most comprehensive recent evidence: 124 women with transplants took prednisone while breastfeeding 169 infants for periods up to 48 months with no reported infant harm 1. Additionally, 34 case reports of infants breastfed during maternal therapy with doses up to 60 mg/day showed no adverse effects 1.
- For doses ≤20 mg daily: Breastfeed normally without timing restrictions 2
- For doses >20 mg daily: The 2025 North American HS guidelines previously suggested waiting 4 hours after dosing 2, but recent 2025 evidence shows this precaution is unnecessary 1
- The infant receives approximately one-sixth of a therapeutic pediatric dose even with high maternal doses 1
Albuterol During Lactation
Albuterol (salbutamol) is compatible with breastfeeding. The 2020 ERS/TSANZ guidelines classify short-acting beta-agonists (SABAs) including albuterol as "compatible" for use during lactation 3. These medications are unlikely to cause structural anomalies, and systemic absorption by the infant through breast milk is minimal. The inhaled route further reduces any potential infant exposure compared to oral administration.
Augmentin (Amoxicillin-Clavulanate) During Lactation
Augmentin is safe during breastfeeding, though monitor for minor gastrointestinal effects in the infant. Multiple high-quality guidelines support its use:
- The 2025 North American HS guidelines suggest using oral amoxicillin/clavulanic acid in breastfeeding patients 2
- The FDA label states that ampicillin-class antibiotics are excreted in human milk and caution should be exercised, but does not contraindicate use 4
- A 2005 prospective study found 22.3% of infants exposed to amoxicillin/clavulanic acid had minor adverse effects (primarily diarrhea, irritability), which was higher than amoxicillin alone (7.5%), but all effects were self-limiting and did not require stopping breastfeeding 5
- The rate of adverse effects increased with higher maternal doses 5
Important Considerations for Augmentin:
- Watch for infant GI symptoms: Loose stools, irritability, or diaper rash may occur but are typically mild and self-resolving
- No need to interrupt breastfeeding: Even if minor symptoms occur, continuing to breastfeed is appropriate
- These effects reflect changes in infant gut flora rather than drug toxicity
Clinical Approach
Continue breastfeeding normally while taking all three medications. The benefits of breastfeeding far outweigh the minimal risks from these medications. The 2020 Anaesthesia guidelines emphasize that short courses of antibiotics are commonly used with no evidence of harmful effects in breastfeeding women 6.
Monitoring Recommendations:
- Observe the infant for drowsiness, poor feeding, or GI symptoms (loose stools, irritability)
- If symptoms occur, they are typically mild and self-limiting
- Contact a healthcare provider if concerning symptoms develop
- Do not discontinue breastfeeding unless specifically advised by a physician
Common Pitfall to Avoid:
Do not unnecessarily interrupt breastfeeding based on outdated concerns about medication safety. The evidence clearly demonstrates that these medications pose minimal risk to breastfed infants, and the well-established benefits of continued breastfeeding outweigh theoretical concerns about drug exposure 7, 8.